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Abstract
Background: The search for risk factors of hypertension requires the study of large populations.
Sometimes, the only feasible way of studying these populations is to rely on self-reported data of
the outcome. The objective of this study was to evaluate validity of self-reported diagnosis of
hypertension in a cohort of university graduates in Spain.
Methods: The Seguimiento Universidad de Navarra (SUN) Study is a cohort of more than 15,000
university graduates in Spain. We selected a random sample of 79 cohort participants who
reported a diagnosis of hypertension and 48 participants who did not report such diagnosis (76%
participation proportion). Then, we compared information on the self-reported diagnosis of
hypertension and hypertension status as assessed through two personal blood pressure
measurements and an interview. Additionally, we compared self-reported and measured blood
pressure levels with intraclass correlation coefficients and the survival-agreement plot.
Results: From those 79 reporting a diagnosis of hypertension, 65 (82.3%, 95% CI 72.8–92.8) were
confirmed through conventional measurement of blood pressure and the interview. From those 48
that did not report a diagnosis of hypertension, 41 (85.4%, 95% CI 72.4–89.1) were confirmed as
non hypertensives. Results were similar among men and women, but were worse for overweight
and obese individuals, and for those with a family history of hypertension. The agreement between
self-reported and measured blood pressure levels (as a continuous variable), as estimated by the
intraclass correlation coefficient, was 0.35 for both systolic and diastolic blood pressure.
Conclusion: Self-reported hypertension among highly educated participants in a cohort study is a
relatively valid tool to assess the hypertensive status of participants. However, the investigators
should be cautious when using self-reported blood pressure values.
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High blood pressure or hypertension (HT) is a major
health problem in our environment.[1] The low degree of
awareness among the population and the difficulties to
comply with prescribed treatments, stress the importance
of primary prevention of this disease.[2]
The search for risk factors of incident HT requires the
study of large populations. Sometimes, the only feasible
way of studying these populations is to rely on self-
reported data of the outcome. As a consequence, it is of
the utmost importance to assess the validity of that
information.
The validity of the self-reported diagnosis of HT has been
assessed in several populations, including a subsample of
the EPIC-Spain cohort.[3] Results vary depending on the
population and on the gold standard used (conventional
measurement of blood pressure (BP) or examination of
medical records).
Our objective was to assess the validity of self-reported
diagnosis of HT in a random sample of the participants in
the Seguimiento Universidad de Navarra (SUN, Univer-
sity of Navarra Follow-up) study, a cohort study in Spain.
Methods
The SUN Study
The SUN Study is a dynamic cohort of university gradu-
ates, recruited and followed up through mailed question-
naires. The main objective of the study was to assess the
association between a Mediterranean dietary pattern and
the risk of cardiovascular disease, diabetes, obesity, and
HT. Its methods have been extensively described else-
where.[4] Briefly, beginning in December 1999, all gradu-
ates of the University of Navarra, Registered Nurses in
Navarra, and members of other professional associations
received a questionnaire and a letter of invitation, explain-
ing the objectives and design of the study. At December
2004, 17,500 had answered the initial questionnaire, and
the recruitment is permanently open. Every other year, a
follow-up questionnaire is mailed to each participant,
gathering information about new medical diagnosis and
changes in exposures of interest. The SUN Study was
approved by the Institutional Review Board of the Univer-
sity of Navarra, and conforms to the principles embodied
in the Declaration of Helsinki.
Questionnaires
The baseline questionnaire gathered information about
sociodemographic variables, anthropometric measures
(weight, height), lifestyle factors (smoking, physical activ-
ity), diet, and clinical variables. The participants were
asked whether they had ever received a medical diagnosis
of HT, their habitual use of medications, and their most
recent BP measurement (choosing among the following
categories, in mm Hg: lower than 100, 101–110, 111–
120, 121–130, 131–140, 141–150, 151–160, 161–175,
greater than 175 for systolic BP; lower than 60, 61 to 70,
71 to 80, 81 to 90, 91 to 100, 101 to 110, 111 to 120, 121
to 130, greater than 130 for diastolic BP). This question
did not differentiate between casual BP determinations or
more formal BP measurements carried out according to
diagnostic protocols.
The follow-up questionnaire inquired about new diagno-
sis of HT asking whether the participant had been diag-
nosed by a physician since the last questionnaire.
Validation study
In September 2003, there were 2,929 SUN participants
living in the metropolitan area of Pamplona (postal codes
beginning by 310). Among them, 151 referred to be
hypertensive (5.2%). Based in results from the literature,
[3,5,6] we assumed that 80% of them would be true cases
of HT. In order to obtain an 8% precision in the estimates
and expecting 10% of non-response, we selected a ran-
dom sample of 107 individuals that referred a diagnosis
of HT in the baseline or in the two-year follow-up ques-
tionnaires, residing in the metropolitan area of Pam-
plona, that were alive and did not participate in a previous
study on validation of diet and physical activity informa-
tion. Similarly, assuming that 90% of those not reporting
HT would be true normotensives, an 8% precision in the
estimate and a non-response rate of 10%, we randomly
selected 61 individuals, with the same inclusion/exclu-
sion criteria than for the self-reported hypertensives.
We sent them a letter with the objectives of the validation
study, an informed consent form and a contact informa-
tion form (e-mail address, telephone number and hours
to be called), together with a postage-paid envelope. After
three months, non-respondents were sent a second or
third mailing if needed. Finally, we tried to contact non-
respondents by phone or email. A hundred and fifty two
(response rate 90.5%) individuals accepted to participate
in the validation study, 97 (response rate 90.7%) among
the hypertensives and 55 among normotensives (response
rate 90.2%).
After the participants gave their written consent, an
appointment was made at their home, working place, or
the Check up Unit at the University Clinic for the BP
measurement. A structured interview was done including
two BP measurements and a questionnaire about medica-
tion use and lifestyle issues related to HT. Two medical
doctors (AA, JJB) carried out the field work, including the
BP measurements, from September 2003 to November
2004. At the time of the measurement, both studyPage 2 of 7
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participant as defined in the questionnaire.
During the first minutes of the interview and with both
the participant and the investigator sited down, the inves-
tigator explained the participant the objectives of the
study, the type of interview, the BP measurements proce-
dure and the confidentiality of the information. Then, the
first BP measurement was done using an automatic BP
measurement device Omrom M4-I. This device has been
previously validated. [7] After another five minutes, used
to complete the rest of the questionnaire, the second BP
measurement was done. Hypertensive patients under drug
therapy were not asked to stop using antihypertensive
medication, because current use of antihypertensive med-
ication was considered confirmatory of being true
hypertensives.
A total of 127 participants (83.6%) completed the valida-
tion protocol. The remaining 25 (7 normotensives and 18
hypertensives) were lost either because they changed their
contact information and could not be located, they
refused to participate, failed to make an appointment
with the investigator or had changed the place of resi-
dency out of the region and could not make an appoint-
ment in Pamplona. Final participation among
hypertensives and normotensives was, respectively,
78.7% and 73.8%.
Definition of self-reported HT and 'true' HT
We considered a participant had self-reported HT when s/
he answered to have been diagnosed as hypertensive by a
physician either in the basal or in the follow-up question-
naire. Otherwise, s/he was considered as non-hyperten-
sive.
We considered a participant as true hypertensive when the
average of both BP measurements was ≥140 mmHg for
systolic BP and/or ≥ 90 mmHg for diastolic BP, when s/he
was currently using antihypertensive drug treatment or
when s/he presented a medical report with a diagnosis of
HT.[8]
Statistical analysis
We computed the proportion of confirmed cases of HT as
the number of those who reported a diagnosis of HT and
had HT according to our gold standard, divided by all
those reporting a diagnosis of HT. Similarly, we computed
the proportion of confirmed non hypertensives as the
number of those who did not report a diagnosis of HT and
were non hypertensives according to our gold standard,
divided by the total number of individuals non reporting
a HT diagnosis. We studied agreement between self-
reported and measured BP using a random-effects model
intraclass correlation coefficient [9] and the survival-
agreement plot proposed by Luiz et al.[10] In the survival-
agreement plot, the absolute difference Xi between BP
measures was plotted in the x-axis against the proportion
of pair of observations with an absolute difference equal
or lower than Xi using the Kaplan-Meier method.[10] We
also used the modification proposed by Llorca and Del-
gado to detect bias in any of the measurement meth-
ods.[11] According to the proposed modification, we
separated those observations with self-reported BP higher
than measured BP, and those with measured BP higher
than self-reported BP. Then, we compared absolute differ-
ences both groups using the log-rank test.
To compute the sensitivity and the specificity of the self-
reported diagnosis of HT, we estimated the expected dis-
tribution of true and false positives and negatives in the
sampled population, based on the sampling fractions and
the observed percentages of confirmed diagnosis. Then,
we computed the kappa coefficient and the true preva-
lence of HT in that population. Confidence interval (CI)
for the prevalence of HT was estimated as suggested by
Cochran for stratified sampling.[12]
Results
We included 70 men and 57 women in our analyses.
Mean age was 53 among those self-reporting HT and 37
among those not reporting a HT diagnosis (range 22–83
and 23–72 respectively). A total of 60 (47.3%) had a BMI
≥ 25 kg/m2. Table 1 shows the main characteristics of the
study participants.
We confirmed 65 (82.3%) of the 79 self-reported HT cases
(95% CI 72.8–92.8%). Among 48 participants who did
not report a HT diagnosis in the questionnaires, 41
(85.4%, 95% CI 72.4–89.1%) could be considered nor-
motensives according to our gold standard (table 2). In
Table 1: Characteristics of participants in the validation study by 
self-reported HT status.
Self-reported HT 
(n = 79)
Non self-reported HT 
(n = 48)
Women (%) 36.8 54.2
Age
≤ 40 y (%) 16.5 68.8
41–55 y (%) 30.4 22.9
>55 y (%) 53.2 8.2
Body mass index
<25 kg/m2 (%) 40.5 72.9
≥ 25 kg/m2 (%) 59.5 27.1
Family history of HT 
(% yes)
45.6 27.1Page 3 of 7
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instead of 140/90, the proportion of confirmed normo-
tensives increased to 97.9% (95% CI 88.7% to 100%).
There were no antihypertensive drug users among those
reporting no hypertension, and 46% of those reporting a
diagnosis of hypertension (36 out of 79) were taking anti-
hypertensive drugs at the time of the interview. Among
the remaining 43, only 14 (33%) had their BP
measurements under 140/90 and were not receiving drug
treatment for hypertension.
The proportion of confirmed hypertensives was higher
among those groups with an expected higher prevalence
of HT (men, older people, and those with high BMI or
with a family history of HT). The proportion of confirmed
normotensives followed an inverse pattern (table 2).
Taking into account our sampling fractions and assuming
our estimate for the proportion of confirmed hyperten-
sives, we expected that 124 out of the 151 individuals
reporting a medical diagnosis of HT in the source popula-
tion were true hypertensives (true positives) and 27 were
normotensives (false positives).
Likewise, the number of true normotensives (true nega-
tives) in the source population would be 2373 (from
2778 self-reported normotensives) and 405 would be
hypertensives (false negatives). Based on these assump-
tions, the values for sensitivity, specificity and kappa coef-
ficient would be 0.23, 0.99, and 0.31, respectively. The
prevalence of HT in this population was 18.1%.
In spite of the categorization used to collect self-reported
data about BP (see above), we calculated the intraclass
correlation coefficient and its 95% CI to assess the abso-
lute agreement between self-reported BP and directly
measured BP as a continuous variable (Table 3). In gen-
eral, the correlation between self-reported and directly
observed information was low, similar for systolic and
diastolic BP and higher for men than women.
Finally, we used the survival-agreement plot to depict
graphically the agreement between self-reported and BP
measurements (Figure 1). Using the modification of this
method proposed by Llorca and Delgado to detect bias,
we noted that measured systolic BP tended to be higher
than self-reported systolic BP (log-rank test, p = 0.0005).
However, this bias was not apparent for diastolic BP (log-
rank test, p = 1.00).
Table 2: Hypertension status and validity of self-reported hypertension according to relevant variables
N (%) % Confirmed HT 
(95% CI)§
P-value* % Confirmed non-HT 
(95% CI)†
P-value*
Total 127 (100) 82.3 (72.8–92.8) 85.4 (72.4–89.1)
Men 70 (55.1) 85.4 (72.8–92.8) 0.53 77.3 (56.6–89.9) 0.22
Women 57 (44.9) 78.6 (60.5–89.8) 92.3 (75.9–97.9)
Age 0.27 0.73
≤ 40 46 (36.2) 69.2 (42.4–87.3) 87.9 (72.7–95.2)
41–55 35 (27.6) 79.2 (59.5–90.8) 81.8 (52.3–94.9)
>55 46 (36.2) 88.1 (75.0–94.8) 75.0 (30.1–95.4)
Body mass index (kg/m2) 0.84 0.37
<25 67 (52.7) 81.3 (64.9–71.1) 88.6 (74.0–95.5)
≥ 25 60 (47.3) 83.0 (70.9–91.1) 76.9 (49.7–91.8)
Family history of HT 0.01 0.004
No 78 (61.4%) 72.1 (57.3–83.3) 94.3 (81.4–98.4)
Yes 49 (38.6%) 94.4 (81.9–98.5) 61.5 (35.5–82.3)
Biomedical degree 0.72 0.32
No 101 (61.4%) 81.0 (69.6–88.8) 81.6 (66.6–90.8)
Yes 26 (38.6%) 87.5 (64.0–96.5) 100.0 (72.2–100.0)
HT: hypertension. CI: confidence interval.
§True positives (according to both methods)/Positives (according to self-reporting)
† True negatives (according to both methods)/Negatives (according to self-reporting)
* Pearson's chi squaredPage 4 of 7
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Our findings showed an acceptable degree of confirma-
tion of self-reported diagnoses of HT, but the overall
agreement was not very high. Particularly, our assump-
tions for HT prevalence and taking into account the sam-
pling fractions, the sensitivity and the kappa coefficient
were low. On the other side, specificity was excellent.
Although these results may seem discouraging, we should
consider that the use of self-reported diagnoses with low
sensitivity but very high specificity in a cohort study do
not represent a substantial drawback, because it is very
likely that HT, as other chronic diseases, will end eventu-
ally showing themselves up during the follow-up of par-
ticipants. Then, in this particular setting, it would be more
important to retain a high specificity, hoping that in the
long-term new cases of HT will eventually be diagnosed.
In addition, it is important not to forget that all except one
of our false negative cases disappeared when the cut-off
point for HT was 160/95 instead of 140/90 mmHg, and
that there were no individuals taking antihypertensive
medication among those reporting normal blood
pressure.
Several studies with different methodology have evalu-
ated the validity of self-reported diagnosis of HT. For
example, in the EPIC-Murcia cohort, the kappa coefficient
between self-reported and medical record-based diagnosis
of HT was 0.58, but the investigators did not personally
measured the BP of participants, as we did, because their
gold standard were only the clinical records.[3] In the
South Carolina Cardiovascular Disease Prevention
Project, the sensitivity, specificity and positive and
negative predictive values were, respectively, 79, 91, 76
and 93 for white women, and 62, 91, 75, and 85 for white
men, with no differences between overweight and normal
weight subjects.[13] In a sample of Finnish individuals,
self-reported HT was confirmed reviewing medical
records, obtaining similar results.[6] In the National
Health and Nutritional Examination Survey III, the
sensitivity for the self-reported diagnosis of HT was 71%
and the specificity 90%.[14] Other studies have found
similar results. [15-18] Finally, in the Nurses' Health
Study and the Health Professional Follow-up Study, with
a design similar to the SUN Study, the observed concord-
ance rates among true HT diagnosis and self-reported
cases of HT were comparable to ours. [5,19]
Our study has several drawbacks. First, the number of
study subjects was relatively small and, thus, validity esti-
mations had wide confidence intervals. Particularly, the
separate analysis for different subgroups should be inter-
preted cautiously. Second, our 'gold standard', two iso-
lated BP measurements, has a limited validity. Actually,
HT diagnosis should be based on multiple BP measure-
ments, taken on separate occasions. [8,20] Third, our
study design did not allow the direct computation of con-
fidence intervals for sensitivity, specificity and the kappa
statistic. On the other side, the high educational level of
our study participants ensures that health care utilization
and, consequently, HT diagnosis are not influenced by
educational status. And, finally, the physicians that per-
formed the BP measurements were unaware of the ques-
tionnaire answers, making both assessments of HT
Table 3: Intraclass correlation coefficients (95% CI) between self-
reported Blood Pressure* and directly measured blood pressure 
§
Systolic BP Diastolic BP
Total 0.35 (0.09–0.55) 0.35 (0.16–0.51)
Men 0.36 (0.01–0.62) 0.45 (0.20–0.64)
Women 0.30 (0.01–0.54) 0.24 (-0.07–0.51)
≤ 55 years 0.29 (0.02–0.52) 0.23 (-0.04–0.47)
>55 years 0.27 (-0.03–0.53) 0.41 (0.12–0.63)
BP: blood pressure. CI: confidence interval.
* Seven categories for systolic BP (from <100 to >150 mmHg) and 7 
categories for diastolic BP (<60 to >130) were offered for 
participants' choice in the questionnaire. We assigned to each 
category its middle point (95 to 155 mmHg for systolic and 55 to 135 
mmHg for diastolic BP) in order to compute the correlation 
coefficients.
§ The average of two measurements taken 5 minutes apart.
Survival-agreement plot, as proposed by Luiz et al.[10]Figure 1
Survival-agreement plot, as proposed by Luiz et al.[10] The x-
axis shows the absolute difference between self-reported and 
measured blood pressure (BP), and the y-axis shows the pro-
portion of observations with differences that are at least the 
observed difference. Separate lines for systolic and diastolic 
BP.
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for validation studies.
The observed agreement between observed and self-
reported values of systolic and diastolic BP, as expressed
by the intraclass correlation coefficient and the survival-
agreement plot, was not high. However, BP levels have a
high within-person variability and, in fact, BP is very dif-
ficult to track in a population (tracking being defined as
the stability of a certain variable over time or the predict-
ability of later values from earlier measurements).[21] In
fact, systolic BP measurements tended to be higher than
self-reported BP in our population, probably due to a real
increase in BP levels over time and also due to a possible
white-coat effect.[22]
Finally, we acknowledge that some misclassification will
always exist in the self-reported diagnosis of HT. But, on
the other side, the study of large populations would be
unfeasible if we could only rely on conventional measure-
ments, given the high amount of resources required to
perform an accurate diagnosis of HT. The trade-off
between precision and sample size has to be kept in mind.
Conclusion
In conclusion, self-reported HT diagnosis in the SUN
Study participants showed enough validity as to be used
in this large cohort study. However, our results do not
support the use of self-reported BP levels (i.e. a continu-
ous variable) as a valid measurement of usual BP levels.
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